Average Co-Inventor Count = 6.98
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (22 from 1,179 patents)
2. Amgen Inc. (18 from 1,975 patents)
3. Eli Lilly and Company (7 from 4,447 patents)
47 patents:
1. 11173161 - 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
2. 10738046 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
3. 10597392 - Tetrahydropyridopyrazines as modulators of GPR6
4. 10561662 - 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
5. 10407443 - 5-HT3 receptor antagonists
6. 10406157 - Tetrahydropyridopyrazine modulators of GPR6
7. 10273225 - Pyrazines as modulators of GPR6
8. 10179783 - Tetrahydropyridopyrazines as modulators of GPR6
9. 10159677 - 4-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
10. 10125145 - 5-HT3 receptor antagonists
11. 10077266 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
12. 10000468 - Pyrazines as modulators of GPR6
13. 9770450 - 4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139
14. 9770452 - Quinoxaline derivatives as GPR6 modulators
15. 9708313 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators